Anaplrqlia
This test detects antinuclear antibodies in fluid around the lungs to help diagnose autoimmune diseases.
{"The test checks for antibodies that attack your own cells in pleural fluid","It helps diagnose conditions like lupus, rheumatoid arthritis, and other autoimmune disorders","A positive result suggests your immune system may be attacking healthy tissues","Results are interpreted along with your symptoms and other test findings","Your doctor will discuss what your specific results mean for your health"}
Key facts at a glance
- LOINC
- 57010-1
- Short code
- ANA Plr Ql IA
- Synonyms
- ANA Plr Ql IA
- Category
- chemistry
- Sample
- fluid
- Container
- Sterile tube
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- ia
- CPT
- 86038
- Specimen volume
- 2-5 mL
- Stability
- Room temperature: 2h, Refrigerated: 24h
- Hemolysis max
- 300
- TAT
- 4–24 hours
- Order
- routine
What is this test?
The Nuclear Antibody (ANA) test in pleural fluid detects the presence of antinuclear antibodies in the fluid collected from around your lungs (pleural space). Antibodies are proteins that normally help fight off foreign invaders like viruses and bacteria. However, ANA are abnormal antibodies that mistakenly attack your own body's healthy cells, specifically the nucleus of cells. This test uses a laboratory method called immunoassay to determine whether these antibodies are present in your pleural fluid.
Why might I need this test?
Your doctor may order this test if you have a pleural effusion (fluid buildup around your lungs) and they suspect an autoimmune condition may be the cause. This test helps in diagnosing diseases where the immune system attacks the body's own tissues, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, scleroderma, or Sjogren's syndrome. These conditions can sometimes cause inflammation and fluid accumulation around the lungs.
How is the sample collected?
Pleural fluid is collected through a procedure called thoracentesis. During this procedure, a doctor numbs the area and inserts a thin needle between your ribs to withdraw fluid from the pleural space. The collected fluid is then sent to a laboratory where it is tested using immunoassay techniques to detect the presence of nuclear antibodies.
What do the results mean?
The result is reported as either 'positive' (antibodies detected) or 'negative' (no antibodies detected). A positive result indicates that antinuclear antibodies were found in your pleural fluid, which suggests an autoimmune process may be contributing to your pleural effusion. However, a positive result does not automatically mean you have a specific disease. Your doctor will interpret this result together with your symptoms, physical examination findings, and other test results to make an accurate diagnosis. Some people may have low levels of ANA without having an autoimmune disease, which is why clinical correlation is essential.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Is this test painful?
How long does it take to get results?
Do I need to prepare for this test?
What happens if my test is positive?
Can this test diagnose a specific disease?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy